The application of artificial intelligence in the intersection of metabolic dysfunction-associated steatotic liver disease and cardiovascular diseases
There is high comorbidity and complex pathological mechanisms between metabolic dysfunction−associated steatotic liver disease (MASLD) and cardiovascular disease (CVD), and the accuracy of traditional risk assessment tools is insufficient. The paper hi…